[ET Net News Agency, 20 July 2021] HEPALINK (09989) fell 0.98% to HK$10.08.
It hits an intra-day low of HK$10.08, hitting a historical low, and an intra-day high of
HK$10.26. The total shares traded was 100,000, with a value of HK$1.01m. The active
buy/sell ratio is 45:55, with net selling turnover of HK$98,910. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$222,090, with volume
weighted average price of HK$10.095. J.P. MORGAN BRO (HK) accounts for greatest net
responsive selling turnover of HK$126,697, with volume weighted average price of
HK$10.136. The stock has fallen a combined 2.14% over the past 3 consecutive trading days.
The Hang Seng Index now fell 330 points, or 1.2% to 27,159; the Hang Seng China
Enterprises Index now fell 149 points, or 1.5% to 9,809; the Hang Seng TECH Index now fell
122 points, or 1.65% to 7,309; with an overall turnover of HK$72.9b.
The SSE Composite Index now fell 17 points, or 0.5% to 3,521, with an overall turnover
of RMB259.75b.
The SZSE Component Index now fell 62 points, or 0.42% to 14,930, with an overall
turnover of RMB170.2b.
Basic Information
-------------------------------------------
Nominal 10.080 % Chg -0.98%
High 10.260 Low 10.080
Shares Tr 100,000 Turnover 1.01m
10-D SMA 10.288 %H.V 15.223
20-D SMA 10.418 VWAP 10.136
50-D SMA 10.626 RSI14 32.632
-------------------------------------------
Status: Hitting a historical low, active buy/sell ratio is 45:55, with net selling
turnover of HK$98,910, falling a combined 2.14% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HEPALINK (09989) 10.08 -0.98
SIHUAN PHARM (00460) 2.86 -4.03
TRAD CHI MED (00570) 4.91 -2.96
CSPC PHARMA (01093) 10.56 -2.22
SINO BIOPHARM (01177) 7.05 -1.54
3SBIO (01530) 8.21 -5.31
FOSUN PHARMA (02196) 66.70 -0.22
WUXI APPTEC (02359) 183.60 -1.98
HANSOH PHARMA (03692) 31.90 -0.78
PHARMARON (03759) 173.50 -0.80
-------------------------------------------------
(ed)